@article{6de0324f536c47b99470152ee4d76301,
title = "Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease",
abstract = "Fecal Calprotectin (FC) is a validated screening test for intestinal inflammation in Crohn's disease (CD). The objective of the study was to prospectively evaluate the limitations of FC for identifying CD in newly diagnosed untreated pediatric patients and to assess the association of FC levels with disease location and serum inflammatory markers.",
keywords = "Adolescent, Biological Markers, Child, Child, Preschool, Crohn Disease, Feces, Female, Humans, Inflammation, Intestine, Small, Leukocyte L1 Antigen Complex, Male, Prognosis, Prospective Studies",
author = "Ron Shaoul and Marlgozata Sladek and Dan Turner and Anders P{\ae}rregaard and Gabor Veres and Wauters, {Gigi Veereman} and Johanna Escher and Dias, {Jorge Amil} and Paolo Lionetti and Annamaria Staino and Kolho, {Kaija Leena} and {de Ridder}, Lissy and Federica Nuti and Salvatore Cucchiara and Orit Sheva and Arie Levine and {ESPGHAN Porto IBD Group}",
note = "Copyright {\textcopyright} 2012 Crohn's & Colitis Foundation of America, Inc.",
year = "2012",
doi = "10.1002/ibd.21875",
language = "English",
volume = "18",
pages = "1493--7",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "Oxford University Press",
number = "8",
}